2004 Democratic National Convention keynote address

Political leaders need a grand narrative – Rishi Sunak's is a story of decline

Retrieved on: 
Monday, October 2, 2023

Sunak recently watered down his climate change mitigation policies, and refused to “speculate” on the future of rail project HS2.

Key Points: 
  • Sunak recently watered down his climate change mitigation policies, and refused to “speculate” on the future of rail project HS2.
  • The Sunak government is seemingly unable to reverse a harmful narrative or maintain its own.
  • But political leaders are successful when they present a grand narrative and find a way to connect themselves to it.
  • Simply finding a bigger narrative is not enough – political leaders must be compelling characters within their narrative.

Contradictions in Sunak’s narrative

    • The audience (in this case, the voting public) must feel able to personally connect with the narrative and the narrator.
    • It is difficult to align yourself with a revival narrative, or an everyman narrative, from a position of privilege.
    • It’s possible that Sunak’s wealth and privilege may render him singularly incapable of connecting to a bigger narrative at this moment in British history.

A narrative of decline

    • As argued in an article in The Economist: “There is just one problem with this narrative.
    • He may follow the example of Thatcher: when faced with a decline narrative, she chose not to reverse it but to embrace it – and blame it on her opponents.
    • Whatever Sunak decides, reversing the narrative of an impending British collapse or leveraging decline to his advantage, his search for a grand narrative is already replete with incongruities.
    • In the end, the stark realities outside Westminster may force him to acknowledge decline and his role within it.

HOPE Center Harlem to Honor Mental Health Heroes at Annual Event

Retrieved on: 
Monday, June 6, 2022

NEW YORK, June 6, 2022 /PRNewswire/ -- Local and national mental health leaders will be celebrated at the HOPE Center Harlem's HOPE in Action Fundraising Awards Breakfast on June 17. Among those being honored at the 3rd annual event, sponsored by Sugar Hill Capital Partners, are Dr. Torian Easterling, First Deputy Commissioner and Chief equity Officer at the New York City Department of Health & Mental Hygiene, and Rawle Andrews Jr., Executive Director of the American Psychiatric Association Foundation (APAF).

Key Points: 
  • NEW YORK, June 6, 2022 /PRNewswire/ -- Local and national mental health leaders will be celebrated at the HOPE Center Harlem's HOPE in Action Fundraising Awards Breakfast on June 17.
  • Given the growing mental health crisis in the wake of the COVID pandemic, the urgency to identify new treatments and solutions has never been greater, the HOPE Center noted.
  • The breakfast brings together a distinguished group of doctors, mental health scholars, researchers, clinicians, and advocates who have contributed greatly to addressing the health & mental health challenges of our time.
  • The HOPE Center offers free mental health services for individuals, families, and group therapy for adults and teens focused on suicide prevention.

TODAY: Gb Sciences' President and Chief Science Officer Presents Keynote Address on Cannabinoid-Containing Formulations for Parkinson's Disease at 2022 NeuroForum Summit

Retrieved on: 
Monday, May 23, 2022

LAS VEGAS, May 23, 2022 (GLOBE NEWSWIRE) -- Dr. Andrea Small-Howard, President and Chief Science Officer of Gb Sciences (OTCQB:GBLX) , presents a Keynote Address today at this year's NeuroForum Summit on the theme of "Emerging Perspectives in Neurology and Brain Research".

Key Points: 
  • LAS VEGAS, May 23, 2022 (GLOBE NEWSWIRE) -- Dr. Andrea Small-Howard, President and Chief Science Officer of Gb Sciences (OTCQB:GBLX) , presents a Keynote Address today at this year's NeuroForum Summit on the theme of "Emerging Perspectives in Neurology and Brain Research".
  • "A multi-factorial disorder like Parkinson's disease may require a multicomponent drug like ours to successfully manage the symptoms," said Dr. Small Howard.
  • In 2020, the combined direct and indirect costs associated with Parkinson's disease in the United States were estimated at approximately $52 billion.
  • Although the precise causes of Parkinson's disease are unknown, several variables , such as aging, genetic predisposition, and environmental factors or exposure contribute to the disease's progression.